Final 192Week Efficacy and Safety Results of the ADVANCED Trial Comparing 3 Firstline Antiretroviral Regimens

dc.article.end-page9en
dc.article.start-page1en
dc.citation.doi10.1093/OFID/OFAE007en
dc.contributor.authorSimiso Sokhelaen
dc.contributor.authorWillem Venteren
dc.contributor.authorB Boschen
dc.contributor.authorJ Woodsen
dc.contributor.authorGodspower Akpomiemieen
dc.contributor.authorNomathemba Chandiwanaen
dc.contributor.authorAngela Temboen
dc.contributor.authorLucas Hermansen
dc.contributor.authorShane Norrisen
dc.contributor.authorLee Fairlieen
dc.contributor.authorE et alen
dc.date.accessioned2024-12-18T11:18:26Z
dc.date.available2024-12-18T11:18:26Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2328-8957en
dc.identifier.urihttps://hdl.handle.net/10539/43381
dc.journal.titleFinal 192Week Efficacy and Safety Results of the ADVANCED Trial Comparing 3 Firstline Antiretroviral Regimensen
dc.journal.volume11en
dc.titleFinal 192Week Efficacy and Safety Results of the ADVANCED Trial Comparing 3 Firstline Antiretroviral Regimensen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
726.4 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client